The Use of Botulinum Toxin Type A Treatment in Children with Spasticity

Pediatric Neurology

Volumn 29, Issue 4, 2003, Pages 299-301

  Sarioglu, Berrak ^a   Serdaroglu, Gul ^b   Tutuncuoglu, Sarenur ^b   Ozer, Esra A ^a  

^a SSK Tepecik Teaching Hospital   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ARTICLE; BODY WEIGHT; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAIT; GASTROCNEMIUS MUSCLE; HUMAN; MALE; MEASUREMENT; MEDICAL ASSESSMENT; OBSERVATION; PRIORITY JOURNAL; SCALE UP; SPASTICITY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VELOCITY; VIDEOTAPE; WALKING;

EID: 0344393575     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(03)00269-8     Document Type: Article

References (13)

1. Young R.R., Delwade P.J. Drug therapy Spasticity . N Engl J Med. 304:1981;28-33.
2. Hainsworth F., Harrison M.J., Sheldon T.A., et al. A preliminary evaluation of ankle orthoses in the management of children with cerebral palsy. Dev Med Child Neurol. 39:1997;243-247.
3. Diamond M. Rehabilitation strategies for the children with cerebral palsy. Pediatr Ann. 15:1996;230-236.
4. Robinson L.R., Hillel A.D. Botulinum toxin treatment for motor control disorders. Phys Med Rehabil Clin N Am. 4:1993;731-744.
5. Blasi J., Chapman E.R., Link E., et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 365:1993;160-163.
6. Jankovic J., Brin M.F. Therapeutic uses of botulinum toxin. N Engl J Med. 324:1991;1186-1194.
7. Koman L.A., Mooney J.F. III, Smith B.P., et al. Management of spasticity in cerebral palsy with botulinum A toxin Report of a preliminary, randomized, double-blind trial . J Pediatr Orthop. 14:1994;299-303.
8. Boyd R., Graham H.K. Botulinum toxin A in the management of children with cerebral palsy Indications and outcome . Eur J Neurol. 4:(Suppl. 2):1997;S15-S22.
9. Ubhi T., Bhakta B.B., Ives H.L., et al. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child. 83:2000;481-487.
10. Sutherland D.H., Kaufman K.R., Wyatt M.P., et al. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy. Gait Posture. 10:1999;1-9.
11. Cosgrove A.P., Corry I., Graham H.K. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol. 36:1994;386-396.
12. Koman L.A., Mooney J.F., Paterson Smith B., et al. and the BOTOX study group. Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy A randomized, double-blind, placebo-controlled trial . J Pediatr Orthop. 20:2000;108-115.
13. Russman B.S., Tilton A., Gormley M.E. Cerebral palsy A rational approach to a treatment protocol, and the role of botulinum toxin in treatment . Muscle Nerve. 6:(Suppl.):1997;S181-S193.